Download PDF
Aktuelle Neurologie 2009; 36(9): 460-474
DOI: 10.1055/s-0029-1220445
Fort- und Weiterbildung

© Georg Thieme Verlag KG Stuttgart · New York

Diagnostik und Therapie vestibulärer Störungen

Diagnosis and Treatment of Vertigo and DizzinessM.  Strupp, K.  Jahn, A.  Zwergal, M.  Dieterich, T.  Brandt
Further Information

Publication History

Publication Date:
04 November 2009 (online)

Also available at
    Permissions and Reprints

Lernziele

Vertiefung der Kenntnisse zur Anamneseerhebung beim Leitsymptom Schwindel Verbesserung der praktischen Fertigkeiten zur körperlichen Untersuchung des vestibulären Systems, insbesondere des vestibulookulären Reflexes und Durchführung der Lagerungsmanöver Darstellung der Diagnose und Therapie der häufigsten peripheren und zentralen vestibulären Syndrome

Literatur

  • 1 Neuhauser H K. Epidemiology of vertigo.  Curr Opin Neurol. 2007;  20 40-46
    CrossrefPubMedGoogle Scholar
  • 2 Brandt T, Dieterich M, Strupp M. Vertigo – Leitsymptom Schwindel. 2. Auflage. Darmstadt; Steinkopff 2010
    PubMedGoogle Scholar
  • 3 Leigh R J, Zee D. The neurology of eye movements, 4 ed. Oxford, New York; Oxford University Press 2006
    PubMedGoogle Scholar
  • 4 Halmagyi G M, Curthoys I S. A clinical sign of canal paresis.  Arch Neurol. 1988;  45 737-739
    CrossrefPubMedGoogle Scholar
  • 5 Zwergal A, Rettinger N, Frenzel C. et al . A bucket of static vestibular function.  Neurology. 2009;  72 1689-1692
    CrossrefPubMedGoogle Scholar
  • 6 Karlberg M, Hall K, Quickert N. et al . What inner ear diseases cause benign paroxysmal positional vertigo?.  Acta Oto Laryngol. 2000;  120 380-385
    CrossrefPubMedGoogle Scholar
  • 7 Brandt T, Steddin S. Current view of the mechanism of benign paroxysmal positioning vertigo: cupulolithiasis or canalolithiasis?.  J Vestib Res. 1993;  3 373-382
    PubMedGoogle Scholar
  • 8 Brandt T, Steddin S, Daroff R B. Therapy for benign paroxysmal positioning vertigo, revisited.  Neurology. 1994;  44 796-800
    CrossrefPubMedGoogle Scholar
  • 9 Semont A, Freyss G, Vitte E. Curing the BPPV with a liberatory maneuver.  Adv Otorhinolaryngol. 1988;  42 290-293
    PubMedGoogle Scholar
  • 10 Epley J M. The canalith repositioning procedure: for treatment of benign paroxysmal positional vertigo.  Otolaryngol Head Neck Surg. 1992;  107 399-404
    CrossrefPubMedGoogle Scholar
  • 11 Strupp M, Cnyrim C, Brandt T. Vertigo and dizziness: treatment of benign paroxysmal positioning vertigo, vestibular neuritis and Menière's disease. In: Candelise L, ed Evidence-Based Neurology – Management of Neurological Disorders. Oxford; Blackwell Publishing 2007: 59-69
    PubMedGoogle Scholar
  • 12 Brandt T, Huppert D, Hecht J. et al . Benign paroxysmal positioning vertigo: a long-term follow-up (6–17 years) of 125 patients.  Acta Otolaryngol. 2006;  126 160-163
    CrossrefPubMedGoogle Scholar
  • 13 Minor L B, Schessel D A, Carey J P. Menière's disease.  Curr Opin Neurol. 2004;  17 9-16
    CrossrefPubMedGoogle Scholar
  • 14 Sajjadi H, Paparella M M. Menière's disease.  Lancet. 2008;  372 406-414
    CrossrefPubMedGoogle Scholar
  • 15 Strupp M, Huppert D, Frenzel C. et al . Long-term prophylactic treatment of attacks of vertigo in Menière's disease – comparison of a high with a low dosage of betahistine in an open trial.  Acta Otolaryngol (Stockh). 2008;  128 620-624
    PubMedGoogle Scholar
  • 16 Theil D, Arbusow V, Derfuss T. et al . Prevalence of HSV-1 LAT in human trigeminal, geniculate, and vestibular ganglia and its implication for cranial nerve syndromes.  Brain Pathol. 2001;  11 408-413
    CrossrefPubMedGoogle Scholar
  • 17 Strupp M, Zingler V C, Arbusow V. et al . Methylprednisolone, valacyclovir, or the combination for vestibular neuritis.  N Engl J Med. 2004;  351 354-361
    CrossrefPubMedGoogle Scholar
  • 18 Strupp M, Arbusow V, Maag K P. et al . Vestibular exercises improve central vestibulospinal compensation after vestibular neuritis.  Neurology. 1998;  51 838-844
    CrossrefPubMedGoogle Scholar
  • 19 Neuhauser H, Leopold M, von Brevern M. et al . The interrelations of migraine, vertigo, and migrainous vertigo.  Neurology. 2001;  56 436-441
    CrossrefPubMedGoogle Scholar
  • 20 Dieterich M, Brandt T. Episodic vertigo related to migraine (90 cases): vestibular migraine?.  J Neurol. 1999;  246 883-892
    CrossrefPubMedGoogle Scholar
  • 21 Baier B, Winkenwerder E, Dieterich M. „Vestibular migraine”: effects of prophylactic therapy with various drugs. A retrospective study.  J Neurol. 2009;  256 436-442
    CrossrefPubMedGoogle Scholar
  • 22 Best C, Eckhardt-Henn A, Tschan R. et al . Psychiatric morbidity and comorbidity in different vestibular vertigo syndromes. Results of a prospective longitudinal study over one year.  J Neurol. 2009;  256 58-65
    CrossrefPubMedGoogle Scholar
  • 23 Eckhardt-Henn A, Best C, Bense S. et al . Psychiatric comorbidity in different organic vertigo syndromes.  J Neurol. 2008;  255 420-428
    CrossrefPubMedGoogle Scholar
  • 24 Wagner J N, Glaser M, Brandt T. et al . Downbeat nystagmus: aetiology and comorbidity in 117 patients.  J Neurol Neurosurg Psychiatry. 2008;  79 672-679
    CrossrefPubMedGoogle Scholar
  • 25 Kalla R, Deutschlander A, Hufner K. et al . Detection of floccular hypometabolism in downbeat nystagmus by fMRI.  Neurology. 2006;  66 281-283
    CrossrefPubMedGoogle Scholar
  • 26 Strupp M, Schuler O, Krafczyk S. et al . Treatment of downbeat nystagmus with 3,4-diaminopyridine: a placebo-controlled study.  Neurology. 2003;  61 165-170
    CrossrefPubMedGoogle Scholar
  • 27 Kalla R, Glasauer S, Buttner U. et al . 4-Aminopyridine restores vertical and horizontal neural integrator function in downbeat nystagmus.  Brain. 2007;  130 2441-2451
    CrossrefPubMedGoogle Scholar
  • 28 Glasauer S, Kalla R, Buttner U. et al . 4-aminopyridine restores visual ocular motor function in upbeat nystagmus.  J Neurol Neurosurg Psychiatry. 2005;  76 451-453
    CrossrefPubMedGoogle Scholar
  • 29 Strupp M, Kalla R, Dichgans M. et al . Treatment of episodic ataxia type 2 with the potassium channel blocker 4-aminopyridine.  Neurology. 2004;  62 1623-1625
    CrossrefPubMedGoogle Scholar
  • 30 Brandt T, Dieterich M. Phobischer Attacken-Schwankschwindel, ein neues Syndrom.  Münch Med Wochenschr. 1986;  128 247-250
    PubMedGoogle Scholar
  • 31 Brandt T. Phobic postural vertigo.  Neurology. 1996;  46 1515-1519
    CrossrefPubMedGoogle Scholar
  • 32 Brandt T, Huppert D, Dieterich M. Phobic postural vertigo: a first follow-up.  J Neurol. 1994;  241 191-195
    CrossrefPubMedGoogle Scholar
  • 33 Kapfhammer H P, Mayer C, Hock U. et al . Course of illness in phobic postural vertigo.  Acta Neurol Scand. 1997;  95 23-28
    CrossrefPubMedGoogle Scholar
  • 34 Pollak L, Klein C, Stryjer R. et al . Phobic postural vertigo: a new proposed entity.  Isr Med Assoc J. 2003;  5 720-723
    PubMedGoogle Scholar
  • 35 Huppert D, Strupp M, Rettinger N. et al . Phobic postural vertigo – a long-term follow-up (5 to 15 years) of 106 patients.  J Neurol. 2005;  252 564-569
    CrossrefPubMedGoogle Scholar
  • 36 Holmberg J, Karlberg M, Harlacher U. et al . Treatment of phobic postural vertigo. A controlled study of cognitive-behavioral therapy and self-controlled desensitization.  J Neurol. 2006;  253 500-506
    CrossrefPubMedGoogle Scholar
  • 37 Holmberg J, Karlberg M, Harlacher U. et al . One-year follow-up of cognitive behavioral therapy for phobic postural vertigo.  J Neurol. 2007;  254 II89-II92
    PubMedGoogle Scholar

Prof. Dr. Michael Strupp

Neurologische Klinik der LMU und Integriertes Forschungs- und Behandlungszentrum für Schwindel, Gleichgewichts- und Okulomotorikstörungen (IFB LMU), Klinikum Großhadern

Marchioninistr. 15

81377 München

Email: Michael.Strupp@med.uni-muenchen.de

      >